Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

A 20-year-old woman with a rare form of Turner syndrome showed improvement with hormonal therapy and needs comprehensive care.

A girl with a rare genetic disorder had a unique bone condition, highlighting the need for careful diagnosis and suggesting the disorder might be more common than thought.

Early diagnosis of Trichorhinophalangeal syndrome type 1 is crucial for treatment and was achieved through clinical examination and family history.

Sebaceous glands age due to genetic and environmental factors, affecting sebum production and composition.

The document discusses male and female pattern hair loss, its diagnosis methods, FDA-approved treatments like finasteride and minoxidil, their side effects, and the role of lifestyle changes.

The guideline provides healthcare professionals in South Africa with instructions for comprehensive, multidisciplinary gender-affirming care, including HIV prevention and treatment for transgender and gender diverse individuals.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

A misdiagnosed case of HAIR-AN syndrome led to unnecessary surgeries and highlighted the importance of correct diagnosis and treatment.

New understanding and treatments for hair loss are improving, but more research is needed.

Transgender patients in critical care need better-trained medical staff and specific guidelines.

Thyroxine (T4) may help heal skin wounds by promoting new skin and blood vessel growth.

The document summarizes medical findings on topics like heart rhythm treatment, sleep apnea therapy, and various health conditions and treatments.

The conclusion is that endocrinology significantly impacts medicine with various common medications used for treatment.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

Low prolactin in young women may increase heart and metabolism risks.

Non-classic congenital adrenal hyperplasia (NCCAH) can mimic PCOS and requires genetic testing for proper diagnosis and treatment.

Electrical stimulation with a low-calorie diet reduces appetite, weight, and blood pressure in obese people with sleep apnea.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

Insulin-sensitizing drugs like metformin can help with ovulation, weight loss, and lower testosterone in some women with PCOS.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

A new system helps better diagnose and treat female androgenization conditions like PCOS.

Hormonal imbalances, especially high androgen levels and insulin resistance, are linked to worse acne in adult women.

Low-dose glucocorticoid treatment improves pregnancy and birth rates in women with nonclassical 21-hydroxylase deficiency.

Eating well and avoiding synthetic hair products are key for healthy hair.

The document concludes that various hair disorders have different treatments, including medication, surgery, and addressing underlying causes.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

Secondary amenorrhea has many causes and requires thorough evaluation to treat and restore menstrual cycles.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Early diagnosis and treatment of NCCAH can improve symptoms and fertility.